Dementia — the progressive decline in cognitive abilities, impacting memory, language and reasoning — affects more than 6 million Americans and accounts for over 100,000 deaths each year.

Among the 329 patients included in the analysis, the mean age was 53±13 years, and 74% were women. The average duration of ...

Frimley Health NHS Foundation Trust has recruited its first patient for a weekly injection to tackle thyroid eye disease.

A small case-control study found potential molecular evidence that links human papillomavirus (HPV) to thyroid eye disease ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs ...

An eye test could predict a devastating condition up to seven years earlier. The groundbreaking technology can detect signs of Parkinson’s disease years before symptoms appear. Parkinson's ...

A revolutionary eye test could lead to huge changes in the diagnosis of Parkinson's disease by detecting the condition up to seven years before symptoms manifest. Developed by researchers at ...

Luxturna, a treatment for LCA caused by mutations in the RPE65 gene, was the first gene therapy approved in the US in 2017 for a genetic disease. To the FDA ... another company developing treatments ...

“Given the failure of the ZEDS [Zoster Eye Disease Study] trial to demonstrate a significant benefit in the primary outcome of new or recurrent disease, it appears difficult to give a blanket ...

It was the last day of his multistate Make American Healthy Again tour, designed to highlight various aspects of Mr. Kennedy’s plan to fight chronic disease, such as healthy school lunches and ...

The lead disease target of Cambridge, Massachusetts-based Merida is Graves’ disease, which develops as antibodies produced by the immune system attack the thyroid gland, a butterfly-shaped gland ...

The company’s lead preclinical program is targeting Graves' disease ... last month after serving as chief operating officer at eye disease biotech Apellis Pharmaceuticals, said the company ...